Is the ‘blue’ colour convention for inhaled reliever medications important? New paper released

Thursday, November 3, 2016

Patients’ lives could be put at risk if pharmaceutical companies stray away from the widely recognised colour coding of inhalers used to treat asthma.

That’s according to UK Inhaler Group (UKIG), which has published the findings of its survey of 3,000 health care professionals and patients. The survey sought to determine the importance of coloured labelling on inhalers used in the treatment of asthma and COPD. 

Visit UKIG's programme page for full details.